Trends in the Treatment of Stage IV Sacral Pressure Ulcers (n=159)

In a recent micro survey hosted by 3S Consulting Group and featured within the WOC Skin Health Weekly® digital publication, respondents were asked to report trends in the treatment of Stage IV Sacral Pressure Ulcers.

“Stage IV Sacral Pressure Ulcers” defined as full thickness tissue loss with exposed bone, tendon, or muscle; slough or eschar may be present on some parts of the wound bed; often includes undermining and tunneling.

Approximately 91% of respondents reported that they routinely treated Stage IV Sacral Pressure Ulcers.

Of those that do, 63% described their clinical certification as Wound Ostomy Continence Nurse. The average number of years of experience in treating Stage IV Sacral Pressure Ulcers ranges between 5-10 years.

The Hospital (54%) is the clinical setting in which Stage IV Sacral Pressure Ulcers are treated most often, followed by Wound Clinic (13%) and Long Term Care (12%).

When debridement is indicated, Sharps (59%) is selected most often for Stage IV Sacral Pressure Ulcers, followed by Enzymatic (22%) and Autolytic (9%).

Type of Debridement: Stage IV Sacral Pressure Ulcers

Those who selected Sharps (surgical) debridement reported the reason for the selection as “Large amount of necrosis/slough” (51%) and “Need for rapid debridement” (43%).

Those who selected Enzymatic debridement reported the reason for selection as “Minimal disturbance to the wound and Peri-wound tissue” (23%), “Minimal trauma to healthy tissue” (23%), and “Ease of use” (19%).

 

Those who selected Autolytic debridement reported the reason for selection as “Minimal trauma to healthy tissue” (42%), “Small amount of necrosis/slough” (25%) and “Minimal disturbance to the wound and Peri-wound tissue” (17%).

Negative Pressure Wound Therapy (NPWT) (25%) is utilized most often as the primary wound dressing for the management of Stage IV Sacral Pressure Ulcers. “Primary” is defined as the dressing which is applied directly to the wound bed.

Primary Dressing: Stage IV Sacral Pressure Ulcers

Those who selected Negative Pressure Wound Therapy (NPWT) as the primary dressing reported the reason for selection as “Accelerate healing” (74.19%), and “Positive patient outcomes” (16%).

 

Those who selected Alginates/Hydrofibers as the primary dressing reported the reason for selection as “Amount of exudate absorbed” (75%), and “Positive patient outcomes” (8%).

Those who selected Silver dressings as the primary dressing reported the reason for selection as “Decrease bioburden/biofilm” (53%), and “Other” (11%).

Please contact your 3S Account Executive if you are interested in more in-depth research on Trends in the Treatment of Stage IV Sacral Pressure Ulcers.